title: Preclinical Studies for Cartilage Repair: Recommendations from the International Cartilage Repair Society.
abstract: Investigational devices for articular cartilage repair or replacement are considered to be significant risk devices by regulatory bodies. Therefore animal models are needed to provide proof of efficacy and safety prior to clinical testing. The financial commitment and regulatory steps needed to bring a new technology to clinical use can be major obstacles, so the implementation of highly predictive animal models is a pressing issue. Until recently, a reductionist approach using acute chondral defects in immature laboratory species, particularly the rabbit, was considered adequate; however, if successful and timely translation from animal models to regulatory approval and clinical use is the goal, a step-wise development using laboratory animals for screening and early development work followed by larger species such as the goat, sheep and horse for late development and pivotal studies is recommended. Such animals must have fully organized and mature cartilage. Both acute and chronic chondral defects can be used but the later are more like the lesions found in patients and may be more predictive. Quantitative and qualitative outcome measures such as macroscopic appearance, histology, biochemistry, functional imaging, and biomechanical testing of cartilage, provide reliable data to support investment decisions and subsequent applications to regulatory bodies for clinical trials. No one model or species can be considered ideal for pivotal studies, but the larger animal species are recommended for pivotal studies. Larger species such as the horse, goat and pig also allow arthroscopic delivery, and press-fit or sutured implant fixation in thick cartilage as well as second look arthroscopies and biopsy procedures.
authors.affiliation: University of Guelph, Guelph, Canada.
authors.forename: Mark B
authors.initials: MB
authors.lastname: Hurtig
authors.affiliation: Ecole Polytechnique Montreal, Montreal, Canada.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Buschmann
authors.affiliation: Cornell University, Ithaca, NY, USA.
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Fortier
authors.affiliation: Ecole Polytechnique Montreal, Montreal, Canada.
authors.forename: Caroline D
authors.initials: CD
authors.lastname: Hoemann
authors.affiliation: University of Bern, Bern, Switzerland.
authors.forename: Ernst B
authors.initials: EB
authors.lastname: Hunziker
authors.affiliation: University of Kuopio, Kuopio, Finland.
authors.forename: Jukka S
authors.initials: JS
authors.lastname: Jurvelin
authors.affiliation: Aginko Research AG, Bern, Switzerland.
authors.forename: Pierre
authors.initials: P
authors.lastname: Mainil-Varlet
authors.affiliation: Colorado State University, Fort Collins, CO, USA.
authors.forename: C Wayne
authors.initials: CW
authors.lastname: McIlwraith
authors.affiliation: University of California, San Diego, CA, USA.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Sah
authors.affiliation: Arthroteq Preclinical Services, Guelph, Canada.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Whiteside
keywords: animal models; cartilage repair; clinical trial; outcome measures; preclinical research